Hsu K S, Lin-Shiau S Y
Institute of Pharmacology, College of Medicine, National Taiwan University, Taipei.
Eur J Pharmacol. 1995 Mar 16;292(3-4):265-70. doi: 10.1016/0926-6917(95)90031-4.
The pharmacological and toxicological activity of pyridine was determined in rat thoracic aorta. Pyridine inhibited norepinephrine (3 microM)-induced phasic and tonic contractions in the thoracic aorta as well as the endothelium-denuded aorta of the rat. The tonic pre-contraction elicited by norepinephrine was also relaxed by the addition of pyridine and this relaxing effect was not affected by indomethacin (20 microM), NG-monomethyl-L-arginine acetate (50 microM) or methylene blue (50 microM). In high-K+ medium (80 mM), pyridine inhibited the Ca2+ concentration-dependent vasocontraction. Moreover, in Ca(2+)-free medium, the norepinephrine (3 microM)-induced phasic contraction was also suppressed by pyridine, while the caffeine (10 mM)-induced contraction remained unaffected. The cAMP and cGMP levels of rat aorta were not changed by pyridine. The 45Ca2+ influx elicited by either norepinephrine or high-K+ was inhibited by pyridine in a concentration-dependent manner. All of these findings indicated that pyridine relaxes rat thoracic aorta by virtue of its Ca2+ channel-blocking properties in vascular smooth muscle.
在大鼠胸主动脉中测定了吡啶的药理和毒理活性。吡啶抑制去甲肾上腺素(3微摩尔)诱导的大鼠胸主动脉以及去内皮胸主动脉的相性和强直性收缩。去甲肾上腺素引起的强直性预收缩也可被加入的吡啶松弛,且这种松弛作用不受吲哚美辛(20微摩尔)、NG-单甲基-L-精氨酸乙酸盐(50微摩尔)或亚甲蓝(50微摩尔)的影响。在高钾培养基(80毫摩尔)中,吡啶抑制钙浓度依赖性血管收缩。此外,在无钙培养基中,吡啶也可抑制去甲肾上腺素(3微摩尔)诱导的相性收缩,而咖啡因(10毫摩尔)诱导的收缩不受影响。吡啶不会改变大鼠主动脉的环磷酸腺苷(cAMP)和环磷酸鸟苷(cGMP)水平。吡啶以浓度依赖性方式抑制去甲肾上腺素或高钾引起的45Ca2+内流。所有这些发现表明,吡啶凭借其在血管平滑肌中的钙通道阻断特性使大鼠胸主动脉松弛。